Intervention Review

Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients

  1. Angela C Webster1,*,
  2. Vincent WS Lee2,
  3. Jeremy R Chapman2,
  4. Jonathan C Craig3

Editorial Group: Cochrane Renal Group

Published Online: 19 APR 2006

Assessed as up-to-date: 19 FEB 2006

DOI: 10.1002/14651858.CD004290.pub2


How to Cite

Webster AC, Lee VWS, Chapman JR, Craig JC. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD004290. DOI: 10.1002/14651858.CD004290.pub2.

Author Information

  1. 1

    University of Sydney, School of Public Health, Sydney, NSW, Australia

  2. 2

    Westmead Hospital, Renal Medicine, Westmead, NSW, Australia

  3. 3

    The Children's Hospital at Westmead, Centre for Kidney Research, Westmead, NSW, Australia

*Angela C Webster, School of Public Health, University of Sydney, Edward Ford Building A27, Sydney, NSW, 2006, Australia. awebster@health.usyd.edu.au. angela.webster@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2006

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.